Efficacy results for progression-free survival

PFS rate % of patients [95% CI]

Chlorphenamine antihistamine n=122 Antihistamine other than chlorphenamine n=300 Any antihistamine plus corticosteroids n=700 Total antihistamine pre-medicated patients n=1122

12-week 66 [58, 75] 58 [52, 64] 61 [57, 65] 61 [58, 64]
24-week 32 [23, 40] 32 [26, 37] 35 [31, 39] 34 [31, 37]
36-week 14 [7, 21] 16 [12, 21] 18 [15, 21] 17 [14, 19]
48-week 5 [1, 9] 6 [3, 9] 6 [4, 8] 6 [4, 8]

PFS=progression-free survival